Updates on Novel Coronavirus (COVID-19)

 

In response to the rapidly changing circumstances associated with the Novel Coronavirus (COVID-19), the ASCP Board of Directors, 2020 Steering Committee, and 2020 Program Committee have made the decision to cancel the ASCP Annual Meeting in-person meeting scheduled to take place May 26 – 29, 2020 in Miami Beach, Florida. Leadership is excited to offer a portion of our 2020 Annual Meeting as a live internet course!

In coming to this decision, ASCP leadership carefully weighed the risks to attendees and their families, colleagues, and patients. ASCP has concerns about the risk to healthcare systems given the medical profile of ASCP attendees and the consequences of potentially displacing healthcare workers during a critical time. Considering all the information available at the moment, ASCP leadership believes that cancelling the in-person conference is the responsible action to take. The health and safety of members, attendees, and the community is its top priority.

Please know this has been an incredibly difficult decision to make for ASCP leadership. ASCP is a not-for-profit organization that depends heavily on its meetings to sustain its financial well-being. Cancelling the in-person Annual Meeting has consequences not just for attendees and presenters but for the very existence of ASCP as a scientific society. Still, ASCP remains committed to its mission to advance the science and practice of clinical psychopharmacology.

The ASCP Annual Meeting brings together over 1200 academic and industry investigators, research pharmacists, and clinicians, including competitively selected New Investigator awardees.  ASCP is joined by federal partners, the National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism, (NIAAA) and the Food and Drug Administration (FDA) to organize a program that emphasizes the presentation of information that has not been previously published or presented. For more information about the history and purpose of the ASCP Annual Meeting please click here.

In recent years, the ASCP Annual Meeting focus has been expanded to address a number of timely issues relevant to clinical research in psychiatry, including the translation of research into practice, the importance of regulatory issues, and pharmacogenetics and other means to personalizing interventions.

Updated:  April 1, 2020